Pundole, Xerxes
Zamora, Natalia V.
Siddhanamatha, Harish
Lin, Heather
Tayar, Jean
Hong, Leung Cheuk
Li, Liang
Suarez-Almazor, Maria E.
Funding for this research was provided by:
Pfizer (ASPIRE #WI195021)
National Cancer Institute (P30 CA016672)
Article History
Received: 12 October 2019
Revised: 20 November 2019
Accepted: 28 November 2019
First Online: 18 December 2019
Compliance with ethical standards
: Institutional review board approval was obtained before any data were collected for this study. The use of patient information complied with the Health Insurance Portability and Accountability Act, and sensitive patient data were protected in the data analysis.
: Xerxes Pundole—noneNatalia V. Zamora—noneHarish Siddhanamatha—noneHeather Lin—noneJean Tayar—noneLeung Cheuk Hong—noneLiang Li—noneMaria E. Suarez-Almazor – Dr. Suarez-Almazor has been a consultant for Pfizer, AbbVie and Agile Pharmaceuticals